Germline Mutation Analysis in Sporadic Breast Cancer Cases with Clinical Correlations
Sadia AjaziD, Sani-e-Zehra ZaidiiD, Saleema Mehboob Ali, Aisha SiddiqaiD, Muhammad Ali MemoniD
Abstract
Demographics for breast cancers vary widely among nations. The frequency of germline mutations in breast cancers, which reflects the hereditary cases, has not been investigated adequately in Pakistani population. In the present case series, germ-line mutations in twenty-seven breast cancer candidate genes were investigated in eighty-four sporadic breast cancer patients along with the clinical correlations. The germ-line variants were also assessed in two healthy gender-matched controls. The most frequent parameters associated with hereditary cancer cases are age and ethnicity. Therefore, the clinico-pathological features were evaluated by descriptive analysis and Pearson X2 test (with significant p-value 40 years) and ethnicity. The breast cancer gene panel assay was carried out by a genomic capture, massively parallel next generation sequencing assay on Illumina Hiseq2000 assay with 100bp read lengths. Copy number variations were determined by partially-mapped read algorithm. Once the mutation was identified, it was validated by Sanger sequencing. The ethnic analysis stratified on the basis of age showed that the frequency of breast cancer at young age (<40 years) was higher in Sindhis (n=12/19; 64%) in contrast to patients in other ethnic groups. Majority of the patients had stage III (38.1%), grades II and III (46.4%), tumor size 2-5cm (54.8%), and invasive ductal carcinoma (81%). Overall, the analysis revealed germ-line mutations in 11.9% of the patients. The mutational spectrum was restricted to three genes: BRCA1, BRCA2, and TP53. The identified mutations consist of seven novel germ-line mutations, while three mutations have been reported previously. All the mutations are predicted to result in protein truncation. No mutations were identified in the remaining twenty-four candidate breast cancer genes. The present study provides the framework for the development of preventive and treatment strategies against breast cancers in Pakistani population.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 7
- FWCI
- 0.76
- Field percentile
- top 34%
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Prevalence and spectrum of germline BRCA1 and BRCA2 mutations in multiethnic cohort of breast cancer patients in Brunei Darussalam
Siti Nur Idayu Matusin, Nuramalina H Mumin, … Mas Rina Wati Haji Abdul Hamid·PLoS ONEPeer-reviewed·Jun 18, 2025
- Very high frequencies of Familial Breast Cancer, low BRCA1/2 mutations and high Luminal molecular subtypes in Eastern Saudi Arabia necessitate the hunt for novel breast cancer hub genes
T. Al-Qurashi, S. Balghonaim, … Z. Iqbal·medRxiv·Oct 3, 2023
- Assessing germline mutational profile and its clinicopathological associations in Triple Negative Breast Cancer
Jisha John, Ashwini C. Bapat, … Chaitanyanand B. Koppiker·Cancer GeneticsPeer-reviewed·Jun 18, 2025
- The clinical and molecular landscape of breast cancer in women of African and South Asian ancestry
Graeme J. Thorn, Emanuela Gadaleta, … Claude Chelala·Nature CommunicationsPeer-reviewed·May 20, 2025
- Assessing the variations in breast/ovarian cancer risk for Chinese BRCA1/2 carriers
Ang Li, Yi Zi, … Yujian Shi·Journal of OncologyPeer-reviewed·Mar 26, 2022
- The genetics of hereditary cancer risk syndromes in Brazil: a comprehensive analysis of 1682 patients
Jarbas Maciel de Oliveira, Nuria Bengala Zurro, … João Bosco Oliveira·European Journal of Human GeneticsPeer-reviewed·May 9, 2022